First Trust Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

First Trust Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-80,346	Closed	-$11M	–	2471
2020 Q3	$11M	Buy	80,346 +41,474	+107%	+$4.41M	0.02%	705
2020 Q2	$3.76M	Sell	38,872 -20,200	-34%	-$1.69M	0.01%	1095
2020 Q1	$2.77M	Buy	59,072 +15,346	+35%	+$983K	0.01%	1115
2019 Q4	$3.19M	Buy	43,726 +3,915	+10%	+$237K	0.01%	1307
2019 Q3	$2.08M	Buy	39,811 +24,695	+163%	+$1.31M	﹤0.01%	1513
2019 Q2	$758K	Buy	15,116 +642	+4%	+$31.3K	﹤0.01%	1962
2019 Q1	$753K	Sell	14,474 -15,091	-51%	-$695K	﹤0.01%	1973
2018 Q4	$1.45M	Buy	29,565 +7,745	+35%	+$426K	﹤0.01%	1655
2018 Q3	$1.42M	Sell	21,820 -17,657	-45%	-$1.04M	﹤0.01%	1828
2018 Q2	$1.96M	Buy	+39,477	New	+$1.91M	﹤0.01%	1633

First Trust Advisors's MYOK Position: Q4 2020 in Review

First Trust Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 80,346 shares — an estimated $11M sold.

First Trust Advisors first reported a position in MYOK in Q2 2018 and held it in 10 quarters. The position peaked at $11M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

First Trust Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
First Trust Advisors sold 80,346 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $11M.
First Trust Advisors first reported a position in MyoKardia, Inc. Common Stock in Q2 2018 and held it in 10 quarters.
First Trust Advisors's MyoKardia, Inc. Common Stock position peaked at $11M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on First Trust Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.